NTRS vs. ARKG

Last updated Aug 5, 2026

NTRS (Northern Trust Corporation) is a stock, while ARKG (ARK Genomic Revolution Multi-Sector ETF) is Health & Biotech Equities fund actively managed by ARK. Over the past 10 years, NTRS returned 13.21%/yr vs 8.50%/yr for ARKG. Their 0.37 correlation means their historical movements had little consistent relationship.

Performance

NTRS vs. ARKG - Performance Comparison

The chart below illustrates the hypothetical performance of a $10,000 investment in Northern Trust Corporation (NTRS) and ARK Genomic Revolution Multi-Sector ETF (ARKG). The values are adjusted to include any dividend payments, if applicable.

Returns By Period

In the year-to-date period, NTRS achieves a 34.92% return, which is significantly lower than ARKG's 40.49% return. Over the past 10 years, NTRS has outperformed ARKG with an annualized return of 13.21%, while ARKG has yielded a comparatively lower 8.50% annualized return.

NTRS

• 1D: 0.12%
• 1M: 3.35%
• 6M: 22.99%
• YTD: 34.92%
• 1Y: 46.14%
• 3Y*: 35.50%
• 5Y*: 13.55%
• 10Y*: 13.21%
• ALL TIME*: 12.59%

ARKG

• 1D: 2.73%
• 1M: -5.15%
• 6M: 34.23%
• YTD: 40.49%
• 1Y: 68.46%
• 3Y*: 6.19%
• 5Y*: -14.37%
• 10Y*: 8.50%
• ALL TIME*: 6.67%

*Multi-year figures are annualized to reflect compound growth (CAGR)

Liquidity Comparison

Position	Avg. Volume Value (2W)	Avg. Volume Value (1M)	Avg. Volume Value (3M)
ARKG ARK Genomic Revolution Multi-Sector ETF	$86.55M	$112.06M	$122.67M
NTRS Northern Trust Corporation	$226.42M	$199.37M	$188.33M

NTRS vs. ARKG - Yearly Performance Comparison

	2026 (YTD)	2025	2024	2023	2022	2021	2020	2019	2018	2017
NTRS Northern Trust Corporation	34.92%	36.92%	25.63%	-1.02%	-23.82%	31.65%	-9.29%	30.59%	-14.68%	14.18%
ARKG ARK Genomic Revolution Multi-Sector ETF	40.49%	23.04%	-28.24%	16.22%	-53.90%	-33.92%	180.40%	44.00%	-1.26%	46.61%

Correlation

The correlation between NTRS and ARKG is 0.38, which is low. Their historical price movements had little consistent relationship.

	Correlation
Correlation (1Y) Focuses on recent behavior, but can change the most.	0.38
Correlation (3Y) Balances recent behavior with more history.	0.43
Correlation (5Y) Shows whether the relationship held over a longer period.	0.44
Correlation (10Y) Provides a long-term view across more market conditions.	0.36
Correlation (All Time) Calculated using the full available price history since Oct 31, 2014	0.37

Return for Risk

NTRS vs. ARKG — Risk / Return Rank

Compare historical risk-adjusted metric ranks over the past 12 months.

NTRS

NTRS Risk / Return Rank: 89
NTRS Sharpe Ratio Rank: 89
NTRS Sortino Ratio Rank: 87
NTRS Omega Ratio Rank: 86
NTRS Calmar Ratio Rank: 90
NTRS Martin Ratio Rank: 90

ARKG

ARKG Risk / Return Rank: 56
ARKG Sharpe Ratio Rank: 59
ARKG Sortino Ratio Rank: 61
ARKG Omega Ratio Rank: 52
ARKG Calmar Ratio Rank: 63
ARKG Martin Ratio Rank: 47

The rank (0–100) uses a weighted average of the Sharpe, Sortino, Omega, Calmar, and Martin percentile ranks for the trailing 12 months. Higher means stronger historical risk-adjusted performance within the peer group.

NTRS vs. ARKG - Risk-Adjusted Trends Comparison

This table presents a comparison of risk-adjusted performance metrics for Northern Trust Corporation (NTRS) and ARK Genomic Revolution Multi-Sector ETF (ARKG). Risk-adjusted metrics are performance indicators that assess an investment's returns in relation to its risk, enabling a more accurate comparison of different investment options.

Values are calculated on a 1-year rolling basis and updated daily. Risk-adjusted metrics are more stable over longer periods — use the period switch above to explore them.

	NTRS	ARKG	Difference
Sharpe ratio: Return per unit of total volatility	1.89	1.60	+0.29
Sortino ratio: Return per unit of downside risk	2.62	2.31	+0.32
Omega ratio: Gain probability vs. loss probability	1.33	1.26	+0.06
Calmar ratio: Return relative to maximum drawdown	3.74	2.50	+1.24
Martin ratio: Return relative to average drawdown	10.29	5.99	+4.31

NTRS vs. ARKG - Sharpe Ratio Comparison

The current NTRS Sharpe Ratio is 1.89, which is comparable to the ARKG Sharpe Ratio of 1.60. The chart below compares the historical Sharpe Ratios of NTRS and ARKG, calculated using daily returns over the previous 12 months. A higher Sharpe Ratio indicates better risk-adjusted performance relative to the risk-free rate.

Drawdowns

NTRS vs. ARKG - Drawdown Comparison

The maximum NTRS drawdown since its inception was -67.67%, smaller than the maximum ARKG drawdown of -83.59%. Use the drawdown chart below to compare losses from any high point for NTRS and ARKG.

Drawdown Indicators

	NTRS	ARKG	Difference
Max Drawdown Largest peak-to-trough decline	-67.67%	-83.59%	+15.92%
Max Drawdown (1Y) Largest decline over 1 year	-12.39%	-27.51%	+15.12%
Max Drawdown (3Y) Largest decline over 3 years	-25.21%	-46.45%	+21.24%
Max Drawdown (5Y) Largest decline over 5 years	-50.03%	-79.00%	+28.97%
Max Drawdown (10Y) Largest decline over 10 years	-50.03%	-83.59%	+33.56%
Current Drawdown Current decline from peak	-4.56%	-63.58%	+59.02%
Average Drawdown Average peak-to-trough decline	-20.88%	-36.29%	+15.41%
Ulcer Index Depth and duration of drawdowns from previous peaks	4.50%	11.48%	-6.98%

Volatility

NTRS vs. ARKG - Volatility Comparison

The current volatility for Northern Trust Corporation (NTRS) is 7.02%, while ARK Genomic Revolution Multi-Sector ETF (ARKG) has a volatility of 11.16%. This indicates that NTRS experiences smaller price fluctuations and is considered to be less risky than ARKG based on this measure. The chart below showcases a comparison of their rolling one-month volatility.

Volatility by Period

	NTRS	ARKG	Difference
Volatility (1M) Calculated over the trailing 1-month period	7.02%	11.16%	-4.14%
Volatility (6M) Calculated over the trailing 6-month period	18.84%	31.32%	-12.48%
Volatility (1Y) Calculated over the trailing 1-year period	24.55%	43.13%	-18.58%
Volatility (5Y) Calculated over the trailing 5-year period, annualized	29.41%	46.22%	-16.81%
Volatility (10Y) Calculated over the trailing 10-year period, annualized	30.23%	41.46%	-11.23%

Dividends

NTRS vs. ARKG - Dividend Comparison

NTRS's dividend yield for the trailing twelve months is around 1.75%, while ARKG has not paid dividends to shareholders.

Position	TTM	2025	2024	2023	2022	2021	2020	2019	2018	2017	2016	2015
ARKG ARK Genomic Revolution Multi-Sector ETF	0.00%	0.00%	0.00%	0.00%	0.00%	0.62%	0.85%	3.14%	0.82%	1.34%	0.00%	0.00%
NTRS Northern Trust Corporation	1.75%	2.27%	2.93%	3.56%	3.28%	2.34%	3.01%	2.45%	2.32%	1.60%	1.66%	1.96%

Frequently Asked Questions

Can I hold both NTRS and ARKG in my portfolio?

NTRS and ARKG have a correlation of 0.38, meaning they provide meaningful diversification benefit when combined. Depending on your allocation goals, holding both could reduce overall portfolio risk.

Which is riskier, NTRS or ARKG?

ARKG has higher volatility (11.16%) compared to NTRS (7.02%). In terms of maximum drawdown, NTRS dropped -67.67% vs ARKG's -83.59%.

Which has better risk-adjusted returns?

NTRS currently has the higher Sharpe Ratio (1.89 vs 1.60), meaning it's delivered slightly more return per unit of risk over the trailing 12 months. However, this ranking shifts over time - use the Risk/Return Score above for a more comprehensive view that combines Sharpe, Sortino, and other measures used by quantitative funds.